期刊文献+

红花黄色素可促进人脐静脉内皮细胞的增殖 被引量:4

Hydroxysafflor yellow A promotes the proliferation of human umbilical vein endothelial cells
下载PDF
导出
摘要 背景:心血管疾病的发生、发展与内皮细胞增生及凋亡有关。目的:观察红花黄色素对血管内皮细胞模型的保护作用。方法:体外培养人脐静脉内皮细胞,先采用红花黄色素进行干预,随后采用溶血卵磷脂体外诱导建立人脐静脉内皮细胞损伤模型,并设置对照组。结果与结论:与对照组比较,溶血卵磷脂干预的人脐静脉内皮细胞增殖减弱(P<0.05),细胞凋亡增加(P<0.05),一氧化氮浓度降低(P<0.01),而经红花黄色素干预后上述现象均可被逆转(P<0.05)。结果证实,红花黄色素可通过促进内皮细胞增殖,抑制其凋亡并增加一氧化氮浓度对溶血卵磷脂诱导的内皮细胞损伤起保护作用。 BACKGROUND:The occurrence and development of cardiovascular diseases are related to the proliferation and apoptosis of vascular endothelial cells (VECs). OBJECTIVE:To investigate the protective effects of hydroxysafflor yellow A (HSYA) on human VEC (hVEC) models. METHODS:The hVECs cultured in vitro were interfered with HSYA and then were established into hVEC injury models by in vitro induction of lysophosphatidyl choline. A control group was set. RESULTS AND CONCLUSION:Compared with the control group, hVECs proliferation was significantly decreased (P 0.05), cell apoptosis was significantly increased (P 0.05) and nitric oxide concentration was significantly decreased (P 0.01) after lysophosphatidyl choline intervention. However, after treatment with HSYA, these symptoms could be reversed (P 0.05). Results showed that HSYA could promote the proliferation of hVECs, inhibit cell apoptosis, and increase nitric oxide concentration, exhibiting protective effects on lysophosphatidyl choline-induced injury to hVECs.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第37期6956-6958,共3页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 吉林省教育厅"十一五"重大科学技术攻关项目(2010123)资助~~
  • 相关文献

参考文献4

二级参考文献19

  • 1臧宝霞,金鸣,李金荣.羟基红花黄色素A抗凝作用的研究[J].中草药,2007,38(5):741-743. 被引量:69
  • 2Jimi S,Saku K,Kusaba H,et al.Deposition of oxidized low-densit lipoprotein and collagenosis occur coincidentally in human coronary stenosis:An immunobistochemical study of atherectomy.Coron Artery Dis,1998,9:551-557.
  • 3Yosefy C,Khalamizer V,Viskoper JR,et al.Impaired nitric oxide production,brachial artery reactivity and fish oil in offspring of ischaemic heart disease patients.Br J Biomed Sci,2003,60:144-148.
  • 4Van HC,Carreer BF,Geczy J,et al.Long-term treatment with the NO-donor molsidomine reduces circulating ICAM-1 levels in patients with stable angina.Atherosclerosis,2005,180:399-405.
  • 5Ohara N,Takeichi S,Naito Y,et al.Remnant-like particles from subjects who died of coronary artery disease suppress NO synthase activity and attenuate endothelium-dependent vasorelaxation.Clin Chim Acta,2003,338(1-2):151-156.
  • 6Asahara T,Bauters C,Pastore C,et al.Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasis in ballon-injured rat carotid artery.Circulation,1995,91:2793-2801.
  • 7Barbier O,Torra IP,Duguay Y,et al.Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.Arterioscler Thromb Vasc Biol,2002,22:717-726.
  • 8Hay JW,Sterling KL.Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease.Pharmacoeconomics,2005,23:133-141.
  • 9Genest J,Frohlich J,Steiner G.Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus.Am J Cardiol,2004,93:848-853.
  • 10Vakkilainen J,Steiner G,Ansquer JC,et al.Relationships between low-density lipoprotein particle size,plasma lipoproteins,and progression of coronary artery disease:the Diabetes Atherosclerosis Intervention Study (DAIS).Circulation,2003,107:1733-1737.

共引文献14

同被引文献75

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部